A bit about me
I genuinely enjoy supporting people and companies as a consultant and partner to reach as many patients as possible in Europe.
Career highlights
Ingo did his doctorate in the Hanover School of Biomolecular Drug Research and focused on bacterial stress response and novel antibiotics. He joined the Kintiga team in July 2019 and has a wealth of market access and HTA leadership experience across a range of therapeutic areas, in particular focusing on challenging situations such as ATMPs, orphan drugs, repurposed drugs and highly competitive indications.
Ingo has actively been involved in shaping the EU HTA development since the very beginning and supports clients as EU HTA Team Lead. During his earlier career he focused on German HTA and pricing strategy, and developed and submitted numerous German AMNOG dossiers. He has always been and still is actively engaged in different national and European associations.
Expertise
- EU market access & pricing strategy
- EU HTA operations and tactics
- Germany Market Access strategy and risk assessment
- Germany AMNOG process, from early access to negotiation
- Strategic advisory across a wide range of indications, focus on challenging situations, orphans, ATMPs, repurposed drugs etc.
Personal interests
Ingo sees himself as a proud family man with a wife and three young children. He is a humorous, reliable person and is interested in politics and soccer, not necessarily in that order. He enjoys traveling with his family and broadening his horizons. However, his greatest passion is disco fox dancing.
